BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24796622)

  • 1. An evaluation of chromogranin A versus gastrin and progastrin in gastrinoma diagnosis and control.
    Rehfeld JF; Bardram L; Hilsted L; Goetze JP
    Biomark Med; 2014; 8(4):571-80. PubMed ID: 24796622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing-independent analysis in the diagnosis of gastrinomas.
    Jørgensen NR; Rehfeld JF; Bardram L; Hilsted L
    Scand J Gastroenterol; 1998 Apr; 33(4):379-85. PubMed ID: 9605259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.
    Siddheshwar RK; Gray JC; Kelly SB
    Gut; 2001 Jan; 48(1):47-52. PubMed ID: 11115822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
    Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
    Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy?
    Bardram L
    Gastroenterology; 1990 Jun; 98(6):1420-6. PubMed ID: 2338186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A in gastrinomas: Promises and pitfalls.
    Rehfeld JF
    Clin Chim Acta; 2015 Jun; 446():15-20. PubMed ID: 25861845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor.
    Kleveland O; Syversen U; Slørdahl K; Waldum HL
    Digestion; 2001; 64(2):71-4. PubMed ID: 11684818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas.
    Abou-Saif A; Gibril F; Ojeaburu JV; Bashir S; Entsuah LK; Asgharian B; Jensen RT
    Cancer; 2003 Jul; 98(2):249-61. PubMed ID: 12872342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and structural characterization of progastrin-derived peptides from a human gastrinoma.
    Huebner VD; Jiang RL; Lee TD; Legesse K; Walsh JH; Shively JE; Chew P; Azumi T; Reeve JR
    J Biol Chem; 1991 Jul; 266(19):12223-7. PubMed ID: 2061307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin in non-neoplastic pancreatic tissue from patients with and without gastrinomas.
    Bardram L
    Scand J Gastroenterol; 1990 Sep; 25(9):935-43. PubMed ID: 2218398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls in diagnostic gastrin measurements.
    Rehfeld JF; Bardram L; Hilsted L; Poitras P; Goetze JP
    Clin Chem; 2012 May; 58(5):831-6. PubMed ID: 22419747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.
    Syversen U; Mignon M; Bonfils S; Kristensen A; Waldum HL
    Acta Oncol; 1993; 32(2):161-5. PubMed ID: 8323758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin processing in primary culture of gastrinoma cells.
    Sobhani I; Elouaer-Blanc L; Pauwels S; Lehy T; Rahier J; Mignon M; Bonfils S; Lewin MJ
    Horm Res; 1989; 32(1-3):71-3. PubMed ID: 2482243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
    Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
    Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating gastrin concentrations in patients at increased risk of developing colorectal carcinoma.
    Paterson AC; Macrae FA; Pizzey C; Baldwin GS; Shulkes A
    J Gastroenterol Hepatol; 2014 Mar; 29(3):480-6. PubMed ID: 24716212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma gastrin and progastrin levels in healthy controls and patients with gastrinoma].
    Azuma T
    Nihon Shokakibyo Gakkai Zasshi; 1986 Jul; 83(7):1407. PubMed ID: 3784074
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of tissue progastrin concentrations in the rat.
    Varro A; Yegen B; Dockray GJ
    Exp Physiol; 1993 May; 78(3):327-36. PubMed ID: 8329207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased tissue concentrations of the gastrin precursor in patients treated with omeprazole.
    Nemeth J; Varro A; Bridson J; Walker R; Dockray GJ
    Eur J Clin Invest; 1992 Oct; 22(10):638-44. PubMed ID: 1459168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of recombinant progastrin in sheep.
    Paterson AC; Baldwin GS; Shulkes A
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E449-56. PubMed ID: 12169437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of gastrinomas with antibodies specific to different fragments of progastrin.
    Sobhani I; Elouaer-Blanc L; Lehy T; Rahier J; Pauwels S; Mignon M; Bonfils S; Lewin MJ
    Gastroenterol Clin Biol; 1989 Nov; 13(11):865-72. PubMed ID: 2482214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.